- Home
- BEN vs PEN Comparison
BEN vs PEN Comparison
Compare BEN & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEN
- PEN
- Stock Information
- Founded
- BEN 1947
- PEN 2004
- Country
- BEN United States
- PEN United States
- Employees
- BEN N/A
- PEN N/A
- Industry
- BEN Investment Managers
- PEN Medical/Dental Instruments
- Sector
- BEN Finance
- PEN Health Care
- Exchange
- BEN Nasdaq
- PEN Nasdaq
- Market Cap
- BEN 12.1B
- PEN 9.7B
- IPO Year
- BEN N/A
- PEN 2015
- Fundamental
- Price
- BEN $22.66
- PEN $248.46
- Analyst Decision
- BEN Hold
- PEN Strong Buy
- Analyst Count
- BEN 12
- PEN 16
- Target Price
- BEN $23.29
- PEN $304.38
- AVG Volume (30 Days)
- BEN 5.1M
- PEN 331.7K
- Earning Date
- BEN 11-07-2025
- PEN 11-05-2025
- Dividend Yield
- BEN 5.75%
- PEN N/A
- EPS Growth
- BEN N/A
- PEN 916.05
- EPS
- BEN 0.52
- PEN 3.74
- Revenue
- BEN $8,638,200,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- BEN N/A
- PEN $15.52
- Revenue Next Year
- BEN $4.80
- PEN $14.20
- P/E Ratio
- BEN $42.53
- PEN $66.60
- Revenue Growth
- BEN 4.67
- PEN 12.92
- 52 Week Low
- BEN $16.25
- PEN $198.68
- 52 Week High
- BEN $26.08
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- BEN 41.10
- PEN 42.95
- Support Level
- BEN $21.96
- PEN $242.80
- Resistance Level
- BEN $23.32
- PEN $254.55
- Average True Range (ATR)
- BEN 0.61
- PEN 7.46
- MACD
- BEN -0.01
- PEN -0.70
- Stochastic Oscillator
- BEN 35.85
- PEN 24.92
About BEN Franklin Resources Inc.
Franklin Resources provides investment services for individual and institutional investors. At the end of July 2025, Franklin had $1.617 trillion in managed assets, composed primarily of equity (41%), fixed-income (27%), multi-asset/balanced (11%) funds, alternatives (16%) and money market funds (5%). Distribution tends to be weighted between retail investors (56% of AUM) and institutional accounts (41%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 31% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.